0001728328-18-000001.txt : 20180117 0001728328-18-000001.hdr.sgml : 20180117 20180117165951 ACCESSION NUMBER: 0001728328-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180117 DATE AS OF CHANGE: 20180117 EFFECTIVENESS DATE: 20180117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303472 FILM NUMBER: 18532076 BUSINESS ADDRESS: STREET 1: SUITE 340 - 200 GRANVILLE STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1S4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 340 - 200 GRANVILLE STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1S4 D 1 primary_doc.xml X0708 D LIVE 0001728328 InMed Pharmaceuticals Inc. SUITE 340 - 200 GRANVILLE STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 1S4 (604) 669-7207 BRITISH COLUMBIA, CANADA Meridex Network Corporation Meridex Software Corporation Cannabis Technologies Inc None Corporation true Eric A. Adams Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Executive Officer Director Martin Bott Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Director Adam Cutler Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Director William J. Garner Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Director Andrew Hull Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Director Jeff Charpentier Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Executive Officer Sazzad Hossain Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Executive Officer Alexandra D.J. Mancini Suite 340 - 200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1S4 Executive Officer Pharmaceuticals No Revenues 06b false 2018-01-03 true true true true true Units, each comprised of one common share and one share purchase warrant exercisable at CAD$1.25 for 18 months false 0 Canaccord Genuity Corp. None Canaccord Genuity Inc. 1020 535 Madison Avenue New York NY NEW YORK 10022 NY NEW YORK false 4551022 1633700 2917322 US dollar amounts herein have been converted from Canadian dollars based on the 0.7979 Bank of Canada daily exchange rate in effect on 1-3-18. Total Remaining to be Sold represents the aggregate exercise price of all warrants sold in the offering. false 2 0 67722 0 true Proceeds from the offering may be used for general working capital purposes. Thus, proceeds may be used for payments to officers and directors in the ordinary course, but they are not specifically earmarked for such payments. false InMed Pharmaceuticals Inc. /s/ Jeff Charpentier Jeff Charpentier Chief Financial Officer 2018-01-17